Photo from Thomas LeBlanc/X
Feb 29, 2024, 05:15
Thomas LeBlanc: I signed ASCO’s letter to end the drug shortage crisis
Thomas LeBlanc, Chief Patient Experience and Safety Officer for the Duke Cancer Institute, shared on X/Twitter:
“I signed ASCO’s letter from America’s cancer doctors and providers urging policymakers to end the drug shortage crisis. Patients are still struggling to get the treatments they need.
Add your voice to the push for solutions and sign the letter!”
Further details.
Source: Thomas LeBlanc/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 2, 2025, 08:07
Aug 2, 2025, 06:54
Aug 2, 2025, 06:37
Aug 2, 2025, 00:00